Phase 1 11 trials
Phase 1
NCT03960489 Jul → Oct 2019 —
Astellas Pharma Global Development, Inc.
Completed
No outcome recorded
Phase 1
NCT02965040 Dec 2016 → Dec 2017 impaired renal function disease , medulloadrenal hyperfunction Astellas Pharma Europe B.V.
Completed
No outcome recorded
Phase 1
NCT02952040 Nov → Dec 2016 —
Astellas Pharma Inc
Completed
No outcome recorded
Phase 1
NCT02805374 Jul → Aug 2016 —
Astellas Pharma Inc
Completed
No outcome recorded
Phase 1
NCT02693613 Feb → Apr 2016 —
Astellas Pharma Inc
Completed
No outcome recorded
Phase 1
NCT02161224 Sep → Dec 2013 liver disorder Astellas Pharma Europe B.V.
Completed
No outcome recorded
Phase 1
NCT02252731 Sep → Nov 2013 —
Astellas Pharma Europe B.V.
Completed
No outcome recorded
Phase 1
NCT02161796 Sep → Dec 2013 —
Astellas Pharma Europe B.V.
Completed
No outcome recorded
Phase 1
NCT01376063 Mar → May 2010 —
Kyntra Bio
Completed
No outcome recorded
Phase 1
NCT01083888 Feb → Jun 2010 anemia , impaired renal function disease Astellas Pharma Inc
Completed
No outcome recorded
Phase 1
NCT00978198 Sep 2009 → Jun 2010 —
Astellas Pharma Inc
Completed
No outcome recorded
Show 1 more trial Phase 1/2 3 trials
Phase 1/2
NCT06917950 Apr → Oct 2025 overdue end stage renal failure , mixed anxiety and depressive disorder Mansoura University
Recruiting
No outcome recorded
Phase 1/2
NCT06903559 Apr → Oct 2025 overdue cardiovascular disorder , chronic renal failure syndrome , end stage renal failure , protein-energy malnutrition Mansoura University
Recruiting
No outcome recorded
Phase 1/2
NCT06020833 Aug 2023 → Oct 2025 myelodysplastic syndrome Peking Union Medical College Hospital
Withdrawn
No outcome recorded
Phase 2 12 trials
Phase 2
NCT05010460 Sep 2021 → May 2025 —
Peking Union Medical College Hospital
Terminated
No outcome recorded
Phase 2
NCT04803864 Jun 2021 → Sep 2022 ST-elevation myocardial infarction Ruijin Hospital
Unknown
No outcome recorded
Phase 2
NCT04076943 Aug 2019 → Mar 2021 chemotherapy-induced toxicity Kyntra Bio
Completed
No outcome recorded
Phase 2
NCT01964196 Sep 2013 → Jul 2015 —
Astellas Pharma Inc
Completed
No outcome recorded
Phase 2
NCT01888445 Mar 2013 → Sep 2014 anemia due to chronic disorder Astellas Pharma Inc
Completed
No outcome recorded
Phase 2
NCT01630889 May 2012 → Dec 2019 anemia , end stage renal failure Kyntra Bio
Completed
No outcome recorded
Phase 2
NCT01599507 Dec 2011 → Jan 2013 anemia due to chronic disorder Kyntra Bio
Completed
No outcome recorded
Phase 2
NCT01596855 Sep 2011 → Jan 2013 aregenerative anemia Kyntra Bio
Completed
No outcome recorded
Phase 2
NCT01414075 Jul 2011 → Jan 2013 anemia Kyntra Bio
Completed
No outcome recorded
Phase 2
NCT01244763 Oct 2010 → Jun 2012 anemia , chronic kidney disease Kyntra Bio
Completed
No outcome recorded
Phase 2
NCT01147666 May 2010 → Oct 2012 anemia , end stage renal failure Kyntra Bio
Completed
No outcome recorded
Phase 2
NCT00761657 Nov 2006 → Jun 2010 anemia , chronic kidney disease Kyntra Bio
Completed
No outcome recorded
Show 2 more trials Phase 2/3 1 trial
Phase 2/3
NCT03303066 Jun 2018 → Jan 2023 anemia , myelodysplastic syndrome Kyntra Bio
Completed
No outcome recorded
Phase 3 24 trials
Phase 3
NCT06772272 Nov 2024 → Nov 2026 expected anemia Second Affiliated Hospital, School of Medicine, Zhejiang University
Active not recruiting
No outcome recorded
Phase 3
NCT05970172 Jan 2024 → Oct 2027 expected anemia , chronic kidney disease Astellas Pharma Global Development, Inc.
Recruiting
No outcome recorded
Phase 3
NCT04621331 May 2022 anemia due to chronic disorder Kyntra Bio
Withdrawn
No outcome recorded
Phase 3
NCT05301517 Mar 2022 → Apr 2023 aregenerative anemia Kyntra Bio
Completed
No outcome recorded
Phase 3
NCT04925011 Sep 2021 → Jun 2022 anemia due to chronic disorder Mao Jianhua
Unknown
No outcome recorded
Phase 3
NCT04484857 Jul 2020 → Jul 2021 end stage renal failure Kyntra Bio
Completed
No outcome recorded
Phase 3
NCT04410198 May 2020 → Jun 2021 end stage renal failure Kyntra Bio
Completed
No outcome recorded
Phase 3
NCT03263091 Jan 2018 → Mar 2023 anemia , myelodysplastic syndrome Kyntra Bio
Terminated
No outcome recorded
Phase 3
NCT02988973 Jan 2017 → Sep 2019 chronic kidney disease Astellas Pharma Inc
Completed
No outcome recorded
Phase 3
NCT02964936 Jan 2017 → Aug 2018 chronic kidney disease Astellas Pharma Inc
Completed
No outcome recorded
Phase 3
NCT02952092 Nov 2016 → Mar 2018 chronic kidney disease Astellas Pharma Inc
Completed
No outcome recorded
Phase 3
NCT02780726 Jun 2016 → Aug 2017 chronic kidney disease Astellas Pharma Inc
Completed
No outcome recorded
Phase 3
NCT02780141 Jun 2016 → Dec 2017 —
Astellas Pharma Inc
Completed
No outcome recorded
Phase 3
NCT02779764 May 2016 → May 2017 aregenerative anemia Astellas Pharma Inc
Completed
No outcome recorded
Phase 3
NCT02652806 Dec 2015 → Jan 2017 anemia Kyntra Bio
Completed
No outcome recorded
Phase 3
NCT02652819 Dec 2015 → Jan 2017 anemia Kyntra Bio
Completed
No outcome recorded
Phase 3
NCT02273726 Jan 2015 → Sep 2018 —
Kyntra Bio
Completed
No outcome recorded
Phase 3
NCT02278341 Nov 2014 → Jun 2017 anemia , end stage renal failure Astellas Pharma Europe B.V.
Completed
No outcome recorded
Phase 3
NCT02174731 Jul 2014 → Sep 2018 anemia AstraZeneca
Completed
No outcome recorded
Phase 3
NCT02174627 Jun 2014 → Oct 2018 anemia AstraZeneca
Completed
No outcome recorded
Phase 3
NCT02021318 Mar 2014 → Mar 2018 aregenerative anemia Astellas Pharma Europe B.V.
Completed
No outcome recorded
Phase 3
NCT02052310 Feb 2014 → Sep 2018 anemia Kyntra Bio
Completed
No outcome recorded
Phase 3
NCT01887600 Sep 2013 → Nov 2017 —
Astellas Pharma Europe B.V.
Completed
No outcome recorded
Phase 3
NCT01750190 Nov 2012 → Sep 2018 chronic kidney disease Kyntra Bio
Completed
No outcome recorded
Show 14 more trials Phase 4 8 trials
Phase 4
NCT07162090 Sep 2025 → Sep 2026 expected anemia due to chronic disorder , muscular atrophy Tianjin Medical University General Hospital
Not yet recruiting
No outcome recorded
Phase 4
NCT06006949 Aug 2023 → Aug 2024 myelodysplastic syndrome Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 4
NCT06115421 May 2023 → Aug 2024 aregenerative anemia Alexandria University
Completed
No outcome recorded
Phase 4
NCT05691257 Feb → Aug 2023 anemia , chronic kidney disease , heart failure China-Japan Friendship Hospital
Unknown
No outcome recorded
Phase 4
NCT07359027 Nov 2021 → Dec 2022 anemia , diabetic kidney disease Second Xiangya Hospital of Central South University
Completed
No outcome recorded
Phase 4
NCT04655027 Feb → Oct 2021 anemia due to chronic disorder AstraZeneca
Completed
No outcome recorded
Phase 4
NCT04454879 Jul 2020 → Apr 2021 anemia Peking University First Hospital
Completed
No outcome recorded
Phase 4
NCT04059913 Jun 2019 → Nov 2021 —
Kyntra Bio
Completed
No outcome recorded
Phase not applicable 1 trial
— NCT05053893 Sep 2021 → Jul 2022 cardio-renal syndrome The Affiliated Hospital of Qingdao University
Unknown
No outcome recorded